Clinical Trial Update: Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a cannabinoid analgesic to an opioid for pain control after photorefractive keratectomy has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Cannabinoid
• Opioid

Snippet

Sponsor: University of Florida | Conditions: Photorefractive Keratectomy, Myopia | Phase 2 | Status: COMPLETED | Results posted: 2025-08-07